| 03/25/2026 3:28 PM | Bionano Genomics (1411690) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 03/23/2026 3:04 PM | Bionano Genomics (1411690) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 03/23/2026 3:08 PM | Bionano Genomics (1411690) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/17/2026 1:46 PM | Bionano Genomics (1411690) Subject CVI Investments, Inc. (1649553) Filed by | Form SCHEDULE 13G/A | |
| 02/04/2026 3:14 PM | Bionano Genomics (1411690) Issuer Holmlin R. Erik (1579988) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/12/2026 7:15 AM | Bionano Genomics (1411690) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 11/14/2025 2:10 PM | Bionano Genomics (1411690) Subject Iroquois Capital Management, LLC (1481867) Filed by | Form SCHEDULE 13G/A | |
| 11/14/2025 1:44 PM | Bionano Genomics (1411690) Subject Iroquois Capital Management, LLC (1481867) Filed by | Form SCHEDULE 13G/A | |
| 11/13/2025 3:04 PM | Bionano Genomics (1411690) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 10/17/2025 3:32 PM | Bionano Genomics (1411690) Filer | Form 424B5 | |
| 09/24/2025 7:00 PM | Bionano Genomics (1411690) Subject Lind Global Fund III LP (2071860) Filed by | Form SCHEDULE 13G | |
Get the Latest News and Ratings for BNGO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Bionano Genomics and its competitors with MarketBeat's FREE daily newsletter.
|
| 09/22/2025 9:00 AM | Bionano Genomics (1411690) Subject CVI Investments, Inc. (1649553) Filed by | Form SCHEDULE 13G | |
| 09/19/2025 3:34 PM | Bionano Genomics (1411690) Subject INTRACOASTAL CAPITAL, LLC (1646799) Filed by | Form SCHEDULE 13G | |
| 09/18/2025 7:13 AM | Bionano Genomics (1411690) Subject Iroquois Capital Management, LLC (1481867) Filed by | Form SCHEDULE 13G | |
| 09/16/2025 11:15 PM | Bionano Genomics (1411690) Filer | Form EFFECT | |
| 09/16/2025 4:20 PM | Bionano Genomics (1411690) Filer | Form 424B4 | |
| 09/12/2025 4:02 PM | Bionano Genomics (1411690) Issuer OLDAKOWSKI MARK (1745566) Reporting | Form 4/A | |
| 09/12/2025 3:49 PM | Bionano Genomics (1411690) Issuer OLDAKOWSKI MARK (1745566) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/12/2025 3:49 PM | Bionano Genomics (1411690) Issuer Chaubey Alka (1821605) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 09/11/2025 10:26 AM | Bionano Genomics (1411690) Filer | Form S-1 Registration statement under Securities Act of 1933 | |
| 06/18/2025 4:15 PM | Bionano Genomics (1411690) Filer | Form 8-K/A | |
| 06/13/2025 3:24 PM | Bionano Genomics (1411690) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 06/12/2025 3:50 PM | Bionano Genomics (1411690) Issuer Rajkovic Aleksandar (1909592) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 3:50 PM | Bionano Genomics (1411690) Issuer Mamuszka Hannah (1810929) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 3:50 PM | BARKER DAVID L (1189124) Reporting Bionano Genomics (1411690) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 3:50 PM | Bionano Genomics (1411690) Issuer Luderer Albert (1746822) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 3:50 PM | Bionano Genomics (1411690) Issuer Linney Yvonne (1810930) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 3:50 PM | Bionano Genomics (1411690) Issuer Vuori Kristiina MD (1612627) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/12/2025 3:51 PM | Bionano Genomics (1411690) Issuer TWOMEY CHRISTOPHER J (1238935) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 5:58 PM | Bionano Genomics (1411690) Issuer Dixon Jonathan V. (1967837) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 5:58 PM | Bionano Genomics (1411690) Issuer Holmlin R. Erik (1579988) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 5:58 PM | Bionano Genomics (1411690) Issuer Chaubey Alka (1821605) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 5:58 PM | Adamchak Mark (2036536) Reporting Bionano Genomics (1411690) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/03/2025 5:59 PM | Bionano Genomics (1411690) Issuer OLDAKOWSKI MARK (1745566) Reporting | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/12/2025 11:08 AM | Bionano Genomics (1411690) Subject CVI Investments, Inc. (1649553) Filed by | Form SCHEDULE 13G/A | |